Home47N0 • FRA
Citius Pharmaceuticals Inc
€0.00
Nov 29, 11:00:59 PM GMT+1 · EUR · FRA · Disclaimer
StockDE listed securityUS headquartered
Previous close
€3.29
Year range
€3.29 - €3.29
Market cap
26.02M USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD)Jun 2024Y/Y change
Revenue
Operating expense
10.63M22.63%
Net income
-10.57M-24.70%
Net profit margin
Earnings per share
-1.500.00%
EBITDA
-10.63M-22.63%
Effective tax rate
-1.38%
Total assets
Total liabilities
(USD)Jun 2024Y/Y change
Cash and short-term investments
17.91M-46.18%
Total assets
97.09M-12.06%
Total liabilities
10.81M-10.73%
Total equity
86.28M
Shares outstanding
7.23M
Price to book
0.28
Return on assets
-28.31%
Return on capital
-31.85%
Net change in cash
(USD)Jun 2024Y/Y change
Net income
-10.57M-24.70%
Cash from operations
-8.37M12.68%
Cash from investing
Cash from financing
13.72M-0.58%
Net change in cash
5.35M26.93%
Free cash flow
-4.64M29.89%
About
Founded
2007
Employees
22
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
Search
Clear search
Close search
Google apps
Main menu